Greehey Children's Cancer Research Institute
Greehey Children's Cancer Research Institute
Greehey Children's Cancer Research Institute
This phase II trial investigates the effect of combining two immune therapies, atezolizumab and CDX-1127 (varlilumab), with or without cobimetinib, in treating patients with biliary tract cancer that cannot be removed by surgery (unresectable).